Evidence map›Paper›PMID 31158828›Full record

ArticleBiofabrication2019

Multi-cellular engineered living systems: building a community around responsible research on emergence.

Matthew Sample, Marion Boulicault, Caley Allen, Rashid Bashir, Insoo Hyun, Megan Levis, Caroline Lowenthal, David Mertz, Nuria Montserrat, Megan J Palmer and 2 more

Abstract read
In one paragraph

Article in Biofabrication, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Organoids: a systematic review of ethical issues.Stem cell research & therapy · 2022
    Pooled it
  3. Review
  4. Review
  5. The Morphological, Behavioral, and Transcriptomic Life Cycle of Anthrobots.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Matthew SamplePragmatic Health Ethics Research Unit, Institut de recherches cliniques de Montreal and Department of Neurology and Neurosurgery, McGill University, Canada.ORCID 0000-0001-5290-1458
Marion BoulicaultDepartment of Linguistics and Philosophy, Massachusetts Institute of Technology, United States of America.ORCID 0000-0001-5990-2373
Caley AllenCenter for Emergent Behaviors of Integrated Cellular Systems, Massachusetts Institute of Technology, United States of America.
Rashid BashirDepartment of Bioengineering, College of Engineering, Carle Illinois College of Medicine, University of Illinois at Urbana-Champaign, United States of America.
Insoo HyunDepartment of Bioethics, School of Medicine, Case Western Reserve University, United States of America.
Megan LevisDepartment of Chemical and Biomolecular Engineering, University of Notre Dame, United States of America.
Caroline LowenthalCenter for Emergent Behaviors of Integrated Cellular Systems, Massachusetts Institute of Technology, United States of America.
David MertzDepartment of Biomedical Engineering, Georgia Tech College of Engineering and Emory School of Medicine, United States of America.
Nuria MontserratPluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), Spain.
Megan J PalmerCenter for International Security and Cooperation (CISAC), Stanford University, United States of America.
Krishanu SahaDepartment of Biomedical Engineering, University of Wisconsin-Madison; Wisconsin Institute for Discovery, University of Wisconsin-Madison, United States of America.
Jeremiah ZartmanDepartment of Chemical and Biomolecular Engineering, University of Notre Dame, United States of America.ORCID 0000-0001-7195-7203

Funding

Assembly of Novel Gene Editing Particles to Understand Genome Surgery in Patient-Derived CellsR35GM119644 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI SAHA, KRISHANU · 2016 to 2025
$4.0M
NIGMS NIH HHS R35 GM119644
6 · The paper itself

Abstract

Ranging from miniaturized biological robots to organoids, multi-cellular engineered living systems (M-CELS) pose complex ethical and societal challenges. Some of these challenges, such as how to best distribute risks and benefits, are likely to arise in the development of any new technology. Other challenges arise specifically because of the particular characteristics of M-CELS. For example, as an engineered living system becomes increasingly complex, it may provoke societal debate about its moral considerability, perhaps necessitating protection from harm or recognition of positive moral and legal rights, particularly if derived from cells of human origin. The use of emergence-based principles in M-CELS development may also create unique challenges, making the technology difficult to fully control or predict in the laboratory as well as in applied medical or environmental settings. In response to these challenges, we argue that the M-CELS community has an obligation to systematically address the ethical and societal aspects of research and to seek input from and accountability to a broad range of stakeholders and publics. As a newly developing field, M-CELS has a significant opportunity to integrate ethically responsible norms and standards into its research and development practices from the start. With the aim of seizing this opportunity, we identify two general kinds of salient ethical issues arising from M-CELS research, and then present a set of commitments to and strategies for addressing these issues. If adopted, these commitments and strategies would help define M-CELS as not only an innovative field, but also as a model for responsible research and engineering.

Indexed as

Biomedical ResearchCell Engineering

Identifiers

PMID31158828
PMCPMC7551891

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.